{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:08:02Z","timestamp":1772690882373,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.clnu.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T01:57:42Z","timestamp":1646445462000},"page":"1066-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Skeletal muscle is prognostic in resected stage III malignant melanoma"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-7783","authenticated-orcid":false,"given":"Susie","family":"Youn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-0463","authenticated-orcid":false,"given":"Dean T.","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5617-6457","authenticated-orcid":false,"given":"Michael","family":"McCall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Smylie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-3620","authenticated-orcid":false,"given":"Michael B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2022.03.001_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"key":"10.1016\/j.clnu.2022.03.001_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clnu.2022.03.001_bib3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"Goodpaster","year":"2000","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.clnu.2022.03.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.clnu.2022.03.001_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.2016.431","article-title":"The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma","volume":"116","author":"Daly","year":"2017","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clnu.2022.03.001_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jcsm.12538","article-title":"Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma","volume":"11","author":"Chu","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clnu.2022.03.001_bib8","first-page":"821","article-title":"Impact of body composition on outcomes from anti-PD1 +\/-anti-CTLA-4 treatment in melanoma","volume":"8","author":"Young","year":"2020","journal-title":"Immunother Cancer."},{"issue":"13","key":"10.1016\/j.clnu.2022.03.001_bib9","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","article-title":"Sarcopenia as a prognostic factor among patients with stage III melanoma","volume":"18","author":"Sabel","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clnu.2022.03.001_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jso.24003","article-title":"Morphomics predicts response to ipilimumab in patients with stage IV melanoma","volume":"112","author":"Sabel","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2022.03.001_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s40425-019-0699-5","article-title":"The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients","volume":"7","author":"Donnelly","year":"2019","journal-title":"Immunother Cancer."},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40425-019-0512-5","article-title":"Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition","volume":"7","author":"Naik","year":"2019","journal-title":"Immunother Cancer."},{"issue":"23","key":"10.1016\/j.clnu.2022.03.001_bib16","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.clnu.2022.03.001_bib18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2022.03.001_bib19","series-title":"Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes","author":"Williams","year":"2006"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally selected rank statistics","volume":"48","author":"Lausen","year":"1992","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O","article-title":"Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments","volume":"19","author":"Mazumdar","year":"2000","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib25","first-page":"57","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"10.1016\/j.clnu.2022.03.001_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.clnu.2022.03.001_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","article-title":"Obesity and cancer: the oil that feeds the flame","volume":"23","author":"Font-Burgada","year":"2016","journal-title":"Cell Metabol"},{"key":"10.1016\/j.clnu.2022.03.001_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12029-015-9709-0","article-title":"Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy","volume":"46","author":"Lee","year":"2015","journal-title":"J\u00a0Gastrointest Cancer"},{"issue":"5","key":"10.1016\/j.clnu.2022.03.001_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/DCR.0000000000001352","article-title":"The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer","volume":"62","author":"Hopkins","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.clnu.2022.03.001_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.suronc.2015.09.002","article-title":"Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy","volume":"24","author":"Grignol","year":"2015","journal-title":"Surgical Oncology"},{"issue":"11","key":"10.1016\/j.clnu.2022.03.001_bib31","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1245\/s10434-010-1145-6","article-title":"Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma","volume":"17","author":"Cadili","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2022.03.001_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma","volume":"1","author":"Thomas","year":"2015","journal-title":"JAMA Oncol"},{"issue":"19","key":"10.1016\/j.clnu.2022.03.001_bib17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561422000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561422000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:05:47Z","timestamp":1759367147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561422000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0261561422000759"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2022.03.001","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal muscle is prognostic in resected stage III malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}